Objectives To investigate the potential protective effects of evolocumab, a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor, on ischemic stroke and its underlying mechanisms. Materials and methods We established a mouse model with distal middle cerebral artery occlusion. We evalua…